This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004 Jul 21;96(14):1048-9.

doi: 10.1093/jnci/djh225.

Barriers to clinical trial enrollment: are state mandates the solution?

Bruce E Hillner

PMID: 15265958
DOI: 10.1093/jnci/djh225

Editorial

Barriers to clinical trial enrollment: are state mandates the solution?

Bruce E Hillner. J Natl Cancer Inst. 2004.

. 2004 Jul 21;96(14):1048-9.

doi: 10.1093/jnci/djh225.

Author

Bruce E Hillner

PMID: 15265958
DOI: 10.1093/jnci/djh225

No abstract available

PubMed Disclaimer

Comment on

Cancer trial enrollment after state-mandated reimbursement.
Gross CP, Murthy V, Li Y, Kaluzny AD, Krumholz HM. Gross CP, et al. J Natl Cancer Inst. 2004 Jul 21;96(14):1063-9. doi: 10.1093/jnci/djh193. J Natl Cancer Inst. 2004. PMID: 15265967

Similar articles

Patient care cancer clinical trials at the National Cancer Institute: a resource for payers and providers.
Pearson D. Pearson D. Manag Care Q. 2002 Winter;10(1):33-7. Manag Care Q. 2002. PMID: 15988953
Who should be responsible?
Brown E. Brown E. Physician Exec. 1996 Jun;22(6):38-9. Physician Exec. 1996. PMID: 10158532 No abstract available.
Researchers left to guess at outcomes of most cancer clinical trials.
Twombly R. Twombly R. J Natl Cancer Inst. 2009 Jan 21;101(2):72-4. doi: 10.1093/jnci/djn495. Epub 2009 Jan 13. J Natl Cancer Inst. 2009. PMID: 19141774 No abstract available.
Why should we include women and minorities in randomized controlled trials?
Weijer C, Crouch RA. Weijer C, et al. J Clin Ethics. 1999 Summer;10(2):100-6. J Clin Ethics. 1999. PMID: 10633280 Review. No abstract available.
Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.
Privitera M. Privitera M. Epilepsy Res. 2006 Jan;68(1):52-6. doi: 10.1016/j.eplepsyres.2005.09.020. Epilepsy Res. 2006. PMID: 16377139 Review.

See all similar articles

Cited by

A descriptive analysis of state legislation and policy addressing clinical trials participation.
Baquet CR, Mishra SI, Weinberg AD. Baquet CR, et al. J Health Care Poor Underserved. 2009 May;20(2 Suppl):24-39. doi: 10.1353/hpu.0.0156. J Health Care Poor Underserved. 2009. PMID: 19711491 Free PMC article. Review.
Follicular lymphoma in the United States: first report of the national LymphoCare study.
Friedberg JW, Taylor MD, Cerhan JR, Flowers CR, Dillon H, Farber CM, Rogers ES, Hainsworth JD, Wong EK, Vose JM, Zelenetz AD, Link BK. Friedberg JW, et al. J Clin Oncol. 2009 Mar 10;27(8):1202-8. doi: 10.1200/JCO.2008.18.1495. Epub 2009 Feb 9. J Clin Oncol. 2009. PMID: 19204203 Free PMC article.
Effect of state-mandated insurance coverage on accrual to community cancer clinical trials.
Ellis SD, Carpenter WR, Minasian LM, Weiner BJ. Ellis SD, et al. Contemp Clin Trials. 2012 Sep;33(5):933-41. doi: 10.1016/j.cct.2012.06.001. Epub 2012 Jun 8. Contemp Clin Trials. 2012. PMID: 22683991 Free PMC article.
Barriers to recruitment of rural patients in cancer clinical trials.
Virani S, Burke L, Remick SC, Abraham J. Virani S, et al. J Oncol Pract. 2011 May;7(3):172-7. doi: 10.1200/JOP.2010.000158. J Oncol Pract. 2011. PMID: 21886499 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information